Ultragenyx Appoints Eric Olson as Chief Business Officer and Executive Vice President
Provided By GlobeNewswire
Last update: Sep 30, 2025
NOVATO, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced the appointment of Eric Olson as chief business officer (CBO) and executive vice president effective September 22, 2025, following the planned retirement of Thomas Kassberg. Mr. Olson will be responsible for leading the company’s business development, corporate development and alliance management functions.
Read more at globenewswire.comNASDAQ:RARE (10/10/2025, 8:53:22 PM)
After market: 31.5001 +0.05 (+0.16%)31.45
-0.21 (-0.66%)
Find more stocks in the Stock Screener
